Lockheed Martin Q1 2026 slides: munitions ramp amid earnings miss

Lockheed Martin reported Q1 2026 EPS of $6.44 versus $6.74 consensus and revenue of $18.0B versus $18.26B expected, with free cash flow negative at $291M. Despite the miss, the company reaffirmed full-year 2026 guidance for $77.5B-$80.0B in sales and $29.35-$30.25 in EPS, while outlining an $8B-$9B munitions capacity expansion through 2030. Shares fell 4.76% pre-market to $529 after the release.

Analysis

The key market read-through is not the earnings miss itself, but the widening gap between near-term execution noise and multi-year demand visibility. Defense primes with exposure to munitions capacity are likely to outperform peers that are still more dependent on legacy platforms and lumpy sustainment; the incremental dollar of capacity in missiles is scarcer and politically stickier than airframe or radar revenue. That means the market may be underestimating how quickly mix can shift toward higher-priority programs once throughput constraints ease, even if 1H26 remains messy.

Second-order, the ERP-driven cash flow dip matters mostly as a timing issue for 2026 capital allocation, not as a thesis breaker. If management is right, the imbalance between reported earnings and free cash flow should compress over the next 1-2 quarters, and that creates a setup for multiple re-rating once investors stop discounting a temporary working-capital drag. The bigger fundamental risk is that the expanded munitions plan quietly consumes more capital than modeled if supply chain inflation re-accelerates or subcontractor capacity remains tight, which would pressure returns on invested capital in 2027-2029.

Geopolitically, the article reinforces a broader defense-spending regime shift: tactical missile inventories remain the bottleneck, and that should support suppliers across propulsion, seekers, energetics, and specialty metals. The losers are not just non-defense cyclicals; within defense, capital can rotate away from premium-valued primes with softer near-term profitability and toward second-tier component and manufacturing names with leverage to the same munitions cycle. Near-term sentiment is likely still fragile, so the opportunity is to buy duration on the theme rather than chase a one-day bounce.

Key Decisions for Investors

• Buy LMT on further post-earnings weakness over the next 1-3 sessions; target a 6-10% rebound as cash-flow noise fades, with a stop if management reaffirms ERP issues beyond Q2.
• Pair trade: long LMT / short NOC or GD for 1-3 months, betting that munitions capacity monetization and mix shift are better positioned at LMT than at peers with less explicit missile upside.
• Add exposure to missile-supply-chain beneficiaries over 3-12 months via a basket long in specialty metals/propulsion names (e.g., HWM, ATI, CW) as the production buildout pulls through subcontractor demand.
• Sell near-dated puts on LMT only if implied vol stays elevated; the setup favors harvesting fear premium while accepting assignment at a discount to fair value.
• If LMT reclaims its pre-earnings level, trim 25-30% and rotate into a basket of smaller defense suppliers for higher beta to the munitions capex cycle.